Volume 82, Issue 1, Pages (July 2012)

Slides:



Advertisements
Similar presentations
Volume 94, Issue 2, Pages (March 2014)
Advertisements

Volume 81, Issue 11, Pages (June 2012)
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 79, Issue 11, Pages (June 2011)
Volume 83, Issue 5, Pages (May 2013)
Volume 80, Issue 2, Pages (July 2011)
Volume 42, Issue 3, Pages (March 2015)
Volume 79, Issue 9, Pages (May 2011)
Volume 81, Issue 11, Pages (June 2012)
Volume 78, Issue 11, Pages (December 2010)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 81, Issue 2, Pages (January 2012)
Volume 26, Issue 3, Pages (March 2007)
The Th17 immune response in renal inflammation
Volume 78, Issue 4, Pages (August 2010)
Volume 66, Issue 3, Pages (September 2004)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 93, Issue 4, Pages (April 2018)
Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity  Genqing Liang, PhD, Tolga Barker,
Volume 79, Issue 4, Pages (February 2011)
Volume 82, Issue 8, Pages (October 2012)
IL-13-Stimulated Human Keratinocytes Preferentially Attract CD4+CCR4+ T cells: Possible Role in Atopic Dermatitis  Rahul Purwar, Thomas Werfel, Miriam.
Volume 62, Issue 2, Pages (August 2002)
Volume 37, Issue 6, Pages (December 2012)
Volume 68, Issue 4, Pages (October 2005)
Volume 82, Issue 1, Pages (July 2012)
Volume 30, Issue 4, Pages (April 2009)
Volume 87, Issue 2, Pages (February 2015)
Volume 56, Issue 6, Pages (December 1999)
Volume 29, Issue 2, Pages (August 2008)
Volume 77, Issue 5, Pages (March 2010)
Volume 31, Issue 2, Pages (August 2009)
Volume 46, Issue 6, Pages e4 (June 2017)
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice  Shrikant R. Mulay, Dana Thomasova, Mi Ryu,
Volume 142, Issue 2, Pages (February 2012)
Volume 81, Issue 9, Pages (May 2012)
Volume 29, Issue 6, Pages (December 2008)
Volume 34, Issue 1, Pages (January 2011)
Volume 42, Issue 2, Pages (February 2015)
Volume 81, Issue 4, Pages (February 2012)
Volume 29, Issue 1, Pages (July 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 86, Issue 4, Pages (October 2014)
Role of B cells in TH cell responses in a mouse model of asthma
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 2, Pages (January 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 37, Issue 5, Pages (November 2012)
Volume 32, Issue 5, Pages (May 2010)
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
Volume 81, Issue 2, Pages (January 2012)
Volume 29, Issue 1, Pages (July 2008)
Volume 64, Issue 3, Pages (September 2003)
Volume 57, Issue 2, Pages (October 2000)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
Volume 37, Issue 5, Pages (November 2012)
Volume 34, Issue 5, Pages (May 2011)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 19, Issue 1, Pages (July 2003)
Volume 64, Issue 6, Pages (December 2003)
Volume 30, Issue 4, Pages (April 2009)
Volume 59, Issue 5, Pages (May 2001)
Volume 84, Issue 1, Pages (July 2013)
Volume 31, Issue 6, Pages (December 2009)
Volume 86, Issue 5, Pages (November 2014)
Volume 35, Issue 1, Pages (July 2011)
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Volume 13, Issue 11, Pages (December 2015)
Presentation transcript:

Volume 82, Issue 1, Pages 72-83 (July 2012) Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis  Hans-Joachim Paust, Jan-Eric Turner, Jan-Hendrik Riedel, Erik Disteldorf, Anett Peters, Tilman Schmidt, Christian Krebs, Joachim Velden, Hans-Willi Mittrücker, Oliver M. Steinmetz, Rolf A.K. Stahl, Ulf Panzer  Kidney International  Volume 82, Issue 1, Pages 72-83 (July 2012) DOI: 10.1038/ki.2012.101 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Time course of experimental crescentic glomerulonephritis. (a, b) Representative periodic acid–Schiff (PAS) and CD3 staining of control and nephritic kidney sections (original magnification × 400) at days 5 and 20. Quantification of (a, right panel) glomerular crescent formation and (b, right panels) tubulointerstitial and glomerular CD3+ T cell infiltration (n=5–8 per time point). Symbols represent mean values±s.e.m. (c) Representative activation status of blood, spleen, and renal CD4+ T cells during the course of the nephritis. Blots show CD44 and CD62L expression for CD4+ CD45+ cells. Numbers give the % values for naive (CD44low CD62L+), central memory (CD44high CD62L+), and effector or effector memory T cells (CD62L- CD44high) (n=3–6 samples per group). Con, control; d, days; h.p.f., high-power field; NTN, nephrotoxic nephritis. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Renal and systemic T helper (Th)17 and Th1 immune responses show differential time kinetics. (a) Kidney: flow cytometry. Flow cytometric analyses of interferon-γ (IFN-γ) and interleukin (IL)-17 production by renal CD4+ T cells after restimulation with phorbol 12-myristate 13-acetate (PMA)/ionomycin as depicted in representative dot plots. (b) Kidney: flow cytometry. Quantification of IFN-γ- and IL-17-producing renal CD4+ T cells at indicated time points (n=5–8 per time point). (c) Kidney quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR). The time-dependent renal mRNA expression of IFN-γ and IL-17 was assessed by RT-PCR (n=5–8 per time point). (d) Spleen: enzyme-linked immunosorbent assay (ELISA). The systemic immune response was determined by measuring IFN-γ and IL-17 secretion by splenocytes after sheep immunoglobulin G (IgG) restimulation (n=3–7 per time point). Symbols represent mean values±s.e.m. Con, control; d, day; NTN, nephrotoxic nephritis. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 CD4+ T cells are the main producers of interleukin (IL)-17 during the autologous phase of experimental glomerulonephritis. (a) Analysis of IL-17 and interferon (IFN)-γ mRNA expression by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of fluorescence-activated cell–sorted (FACS) CD4+ or CD8+ T cells, as well as CD11b+ cells, isolated from kidneys of nephritic wild-type mice on days (d) 6, 10, and 20 after induction of nephritis and non-nephritic wild-type controls (n=5–6 per group). (b) Representative intracellular IL-17 and IFN-γ FACS analysis of isolated renal leukocytes from control or nephritic mice (on day 6 or 20 after induction of nephritis), gated for CD45+CD3+CD8+ T cells. NTN, nephrotoxic nephritis. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 Time-dependent function of T helper (Th)17 and Th1 immune responses in experimental glomerulonephritis. (a, left panel) Quantification of glomerular crescent formation and the interstitial area in controls (Con), nephritic wild-type (WT), nephritic interleukin (IL)-17-/- and nephritic interferon (IFN)γ-/- mice 6 days after nephritis induction and (a, right panel) at day 20 in nephritic WT mice treated with anti-IL-17, anti-IFN-γ, or control (immunoglobulin G (IgG)) antibodies. (b) Representative immunohistochemical staining of renal Ly6G/C+ neutrophil infiltration (original magnification × 400). Quantification of neutrophil recruitment in nephritic WT, nephritic IL-17-/-, and nephritic IFN-γ-/- mice at day 6 of nephrotoxic nephritis (NTN) (n=3–6 per group). (c) Representative staining and quantification of renal F4/80-positive monocytes/macrophages (M/M) dendritic cells (DCs) (original magnification × 400) 20 days after NTN induction (n=4–5 per group). (d) Blood urea nitrogen (BUN) levels of controls, nephritic WT, nephritic IL-17-/-, and nephritic IFNγ-/- mice on day 6 after induction of nephritis and on day 20 in nephritic WT mice treated with anti-IL-17, anti-IFN-γ, or control (IgG) antibodies. Bars represent means, and error bars indicate s.e.m. (*P<0.05). h.p.f., high-power field. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 5 Transfer experiments of interleukin (IL)-17- or interferon (IFN)-γ-deficient splenocytes into nephritic RAG1-/- mice. (a) Representative periodic acid–Schiff (PAS)-stained kidney sections (original magnification × 400) of RAG1-/- control and nephritic RAG1-/- mice reconstituted with wild-type (WT), IL-17-/-, or IFN-γ-/- splenocytes at day 10 and quantification of glomerular crescent formation and the interstitial area in the different groups (n=4–5 per group). (b) Histogram of renal IL-17- or IFN-γ-producing CD4+ T cells in the different groups of nephritic RAG1-/- mice (percentage of IFN-γ- or IL-17-positive CD4+ T cells are representative of three independent experiments). (c) Renal mRNA expression of IFN-γ and IL-17 was measured by quantitative real-time RT-PCR (qRT-PCR). Data are expressed as x-fold relative to control (n=4 per group). (d) IFN-γ and IL-17 production by restimulated splenocytes was determined by enzyme-linked immunosorbent assay (ELISA) (n=4 per group). (e) Blood urea nitrogen (BUN) levels of the different animal groups. Bars represent means, and error bars indicate s.e.m. (*P<0.05). Con, control; NTN, nephrotoxic nephritis. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 6 Renal CCL20 and CXCL9 expression are differentially regulated by interleukin (IL)-17 and interferon (IFN)γ in vivo and in vitro. (a) Renal mRNA expression of CCL20 and CXCL9 was analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR) during the course of the nephritis. (b) CCL20 and CXCL9 mRNA expression in the kidneys of nephritic wild-type (WT), IL-17-/-, or IFN-γ-/- mice at day (d) 6 (c) or in kidneys from nephritic mice treated with neutralizing anti-IFN-γ or anti-IL-17 antibodies at day 20. Data are expressed as x-fold of control mRNA expression (n=4–6 per group). (d, upper panel) CCL20 and CXCL9 mRNA expression in mouse mesangial cells stimulated with IL-17 (10ng/ml) and/or IFN-γ (10ng/ml) for 4h was assessed by RT-PCR. (d, lower panel) CCL20 and CXCL9 protein production was measured by specific enzyme-linked immunosorbent assay (ELISA) in the supernatants after 18h of stimulation in the presence or absence of IL-17 (10ng/ml) and/or IFN-γ (10ng/ml) (n=4–6 per group). Bars represent means±s.e.m. (*P<0.05). Con, control; IgG, immunoglobulin G; NTN, nephrotoxic nephritis. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 7 CXCR3 and CCR6 regulate renal T helper (Th)1 and Th17 cell recruitment. (a) Representative fluorescence-activated cell sorting (FACS) analysis of renal Th1 and Th17 cells for CXCR3 and CCR6 expression at days (d) 7 and 20 of nephrotoxic nephritis (NTN), respectively (gated for CD4+ T cells). Further gating on interferon (IFN)-γ+ and interleukin (IL)-17+ cells shows differential expression of CXCR3 and CCR6. Numbers are representative of three experiments. (b) Histogram of renal IL-17-producing Th17 cells in kidneys from controls and nephritic wild-type (WT) or nephritic CCR6-deficient mice at day 6 after nephritis induction. (c) Renal IFN-γ-producing Th1 cells were quantified in control, nephritic, and nephritic CXCR3-/- mice at day 20. The numbers of CD4+ T cells producing IL-17 or IFN-γ are representative of three independent experiments. Kidney International 2012 82, 72-83DOI: (10.1038/ki.2012.101) Copyright © 2012 International Society of Nephrology Terms and Conditions